Our world-leading diabetes research and outstanding postgraduate and professional education are underpinned by our expertise in genomics and cutting-edge innovation in technology. Our advances span from discovering biological causes and mechanisms, to improving diagnosis and treatment worldwide, to prevention and supporting people to live healthier lifestyles.

In type 1, type 2 and monogenic diabetes, our research takes a precision medicine approach, and is embedded in clinical practice. This means our discoveries are swiftly implemented to benefit people with diabetes.